Cooley LLP: What happened with shareholder proposals for political spending in the 2022 proxy season? In the NewsBy danJuly 11, 2022
STAT+: ‘A slippery slope’: Pfizer sells a contraceptive and donated to political groups that could come after the company In the NewsBy danJuly 6, 2022
Washington Post Opinion: Abortion rights should be law, not a corporate perk In the NewsBy danJune 30, 2022
Background Report: Corporate Misalignment on Abortion with 527 spending CPA ReportsBy danJune 28, 2022
Financial News: How a small group of BlackRock analysts speaks for millions of investors In the NewsBy danJune 23, 2022
MarketWatch: There’s another reason companies should tread carefully with political influence — the stock market is watching In the NewsBy danJune 13, 2022
Harvard Law School Forum on Corporate Governance: Practical Stake Report In the NewsBy danJune 10, 2022
Washington Post: Stefanik echoed ‘great replacement’ theory. But firms kept donating. In the NewsBy danMay 23, 2022
